Regeneron Pharmaceuticals (NASDAQ: REGN) last traded at $834.04, up 0.90% on the session. The quote above updates while this page is open; the figures below are drawn from Regeneron Pharmaceuticals’s own filings and are restated only when a new one is published.
Regeneron Pharmaceuticals trades on NASDAQ under the ticker REGN. It is classified in the Healthcare sector, Biotech industry. Its market capitalisation is $88.41 billion.
Healthcare sectorBiotechListed on NASDAQ
Valuation measures for Regeneron Pharmaceuticals, derived from the latest quote and its most recent SEC filing.
| Market cap | $88.41B |
|---|---|
| Enterprise value | $95.97B |
| P/E ratio | 20.65 |
| Price / sales | 5.69 |
| Price / book | 2.79 |
| Beta | 0.50 |
Trailing-twelve-month figures tagged in Regeneron Pharmaceuticals's XBRL filings with the SEC.
| Revenue (TTM) | $15.53B |
|---|---|
| Net income (TTM) | $4.33B |
| EPS (TTM) | $40.38 |
| Operating margin | 24.74% |
| Return on equity | 13.65% |
| Cash | $2.46B |
Range and volume for REGN over the past 52 weeks.
| 52-week high | $847.00 |
|---|---|
| 52-week low | $541.00 |
| Volume | 717.7K |
| Average volume | 940.2K |
| Previous close | $826.64 |
Dividend history for Regeneron Pharmaceuticals over the trailing twelve months.
| Dividend yield | 0.44% |
|---|---|
| Dividend per share (TTM) | $3.64 |
| Payout ratio | 9.01% |
Other Healthcare companies tracked on FurlPay Markets.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.